CIK 0001789972 · Non-accelerated filer<br>Smaller reporting company
Cullinan Therapeutics, Inc.
Sign in to watch- Ticker
- CGEM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813879991
- Phone
- 617-410-4650
- Business address
- ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
- Former names
- Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $222,000
- in 2 filings, $222K under 10b5-1 plans
Net −$222,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-07 | Zawel Leigh See Remarks | Grant or award · Stock Option (Right to Buy) | +56,666 | 56,666 | ||
| 2021-01-07 | Michaelson Jennifer See Remarks | Grant or award · Stock Option (Right to Buy) | +79,999 | 79,999 | ||
| 2021-01-07 | Hughes Owen President and CEO | Grant or award · Stock Option (Right to Buy) | +433,332 | 433,332 | ||
| 2021-01-07 | Trigilio Jeffrey Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +146,665 | 146,665 | ||
| 2021-01-07 | Wigginton Jon Marc Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +116,666 | 116,666 | ||
| 2021-01-07 | Keane Raymond T Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +249,998 | 249,998 |
Page 23 of 23 · 446 trades